×
Home
Archive Submission Guidelines
News Contact
Original article
Crossmark

Hepatorenal toxicity of different doses of ketorolac administration in adult male rats: A preclinical study

By
Fatemeh Rashidi ,
Fatemeh Rashidi
Amir Noyani ,
Amir Noyani
Salma Omidi ,
Salma Omidi
Touraj Assadi
Touraj Assadi

Abstract

Ketorolac is a potent non-steroidal anti-inflammatory drug (NSAID) that can inhibit cyclooxygenase activity and prostaglandin synthesis, thereby reducing pain and inflammation. The aim of this study was to investigate the hepatorenal toxicity of ketorolac administration in adult male rats. Twenty-four adult male Wistar rats were randomly assigned to three groups (n = 8 per group): a control group receiving normal saline (1 mL/kg), a low-dose ketorolac group (10 mg/kg), and a high-dose ketorolac group (20 mg/kg). The animals were maintained under standard housing conditions for three weeks after the last treatment. Blood samples were collected under anesthesia, and serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and creatinine (Cr) were measured using commercial kits and a BT 1000 Biotectica analyzer. Compared to the control group, the low-dose ketorolac group did not show a significant increase in ALT and AST levels, but the high-dose ketorolac group exhibited a significant elevation in these hepatic enzymes (P < 0.05). Both the low-dose and high-dose ketorolac groups demonstrated a significant increase in BUN and Cr levels compared to the control group, with the high-dose group showing a more pronounced elevation in these renal parameters (p < 0.05). The findings of this study suggest that high-dose ketorolac administration can induce hepatotoxic and nephrotoxic effects, as evidenced by the increased levels of liver and kidney function markers in adult male rats. These results highlight the importance of careful monitoring and dose optimization when using ketorolac in clinical settings.

References

1.
BRATER D. Anti-inflammatory agents and renal function☆, ☆☆. Seminars in Arthritis and Rheumatism. 2002;32(3):33–42.
2.
Lacroix I, Lapeyre‐Mestre M, Bagheri H, Pathak A, Montastruc JL. Nonsteroidal anti‐inflammatory drug‐induced liver injury: a case–control study in primary care. Fundamental &amp; Clinical Pharmacology. 2004;18(2):201–6.
3.
Leise MD, Poterucha JJ, Talwalkar JA. Drug-Induced Liver Injury. Mayo Clinic Proceedings. 2014;89(1):95–106.
4.
Soleimanpour M, Imani F, Safari S, Sanaie S, Soleimanpour H, Ameli H, et al. The Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review Article. Anesthesiology and Pain Medicine. 6(4).
5.
Rubenstein JH, Laine L. The hepatotoxicity of non‐steroidal anti‐inflammatory drugs. Alimentary Pharmacology &amp; Therapeutics. 2004;20(4):373–80.

Citation

Article metrics

Google scholar: See link

Citations

Crossref Logo

1

Crossref Logo

V.O. Student, F.V. Hladkykh, Т.І. Liadova, M.S. Matvieienko

(2025)

Role of the nitric oxide system and protein homeostasis in the nephroprotective effect of cell-free cryopreserved biological products in a model of ketorolac-induced nephropathy

The Journal of V N Karazin Kharkiv National University series "Medicine", ()

10.26565/2313-6693-2025-57-07

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.